Contract development and manufacturing organization (CDMO) Abzena has announced the formation of a strategic partnership with ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the next five years. Key factors driving this growth include the increasing ...

In the rapidly evolving world of biotechnology and pharmaceuticals, innovation is the key to staying ahead. One of the most ...

"Abzena and Mabqi partner for drug development solution" was originally created and published by Pharmaceutical Technology, a ...

TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which ...

In recent years, the conversation around artificial intelligence (AI) in healthcare has intensified, especially in the realm of drug discovery. Reshma Kewalramani, the CEO of Vertex Pharmaceuticals, ...

Abzena and Mabqi Announce Strategic Partnership to Offer Integrated Discovery through Development SolutionSan Diego, CA & Montpellier, FR – November 6, 2025 – Abzena, the leading end-to-end integrated ...

Abzena and Mabqi form strategic partnership to offer integrated discovery through development solution: San Diego, California Friday, November 7, 2025, 11:00 Hrs [IST] Abzena, the ...

With an AI-led platform for drug discovery and a growing global client base, Medvolt AI is emerging as one of India’s most ...

RNA plays a vital role in how our genes are expressed and how diseases develop. Yet, because RNA molecules constantly change ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

Have you ever wondered how scientists test new medicines before they reach people? The process must be safe, accurate, and ...